Risperidone Microspheres for Injection (Ⅱ)(Luye Pharma)

注射用利培酮微球(Ⅱ)（绿叶制药）

Report date: 2025/12/30 17:51:35

Base Information

Drug NameRisperidone Microspheres for Injection (Ⅱ)(Luye Pharma)
Drug Alias NameRisperidona利司哌酮Risperidonum利螺环酮Risperdal Consta (利培酮) +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryMainland China
Original Approved Date2021/01/12
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShandong Luye Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Luye Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG